{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:38:52Z","timestamp":1791956332048,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["20441"],"award-info":[{"award-number":["20441"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.autrev.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T09:41:37Z","timestamp":1549791697000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Alessio","family":"Buonavoglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Lernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Petruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bonamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9479","key":"10.1016\/j.autrev.2019.02.005_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.02.005_bb0010","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clindermatol.2015.11.006","article-title":"Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica","volume":"34","author":"Broussard","year":"2016","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clindermatol.2011.01.015","article-title":"Oral involvement in autoimmune bullous diseases","volume":"29","author":"Ramos-e-Silva","year":"2011","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1468-3083.2012.04509.x","article-title":"Is conjunctival mucous involvement a marker of severity in pemphigus vulgaris?","volume":"27","author":"Balica","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.autrev.2019.02.005_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1600-0625.2009.00934.x","article-title":"Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis","volume":"18","author":"Grando","year":"2009","journal-title":"Exp Dermatol"},{"issue":"17","key":"10.1016\/j.autrev.2019.02.005_bb0040","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.autrev.2019.02.005_bb0045","first-page":"971","article-title":"The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus","volume":"134","author":"Vu","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0050","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1074\/jbc.M109.081570","article-title":"Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology","volume":"285","author":"Marchenko","year":"2010","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.005_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.autrev.2009.01.011","article-title":"Apoptosis in pemphigus","volume":"8","author":"Schmidt","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/1523-1747.ep12343081","article-title":"Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients","volume":"106","author":"Amagai","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2019.02.005_bb0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1523-1747.2002.01780.x","article-title":"Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion","volume":"119","author":"Hanakawa","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1523-1747.2000.00840.x","article-title":"Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production","volume":"114","author":"Nishifuji","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1","article-title":"Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris","volume":"32","author":"Tsunoda","year":"2002","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2019.02.005_bb0085","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.autrev.2019.02.005_bb0090","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.4049\/jimmunol.178.9.5982","article-title":"Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients","volume":"178","author":"Qian","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0095","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.172.6.3883","article-title":"T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.det.2011.03.020","article-title":"The genetics of pemphigus","volume":"29","author":"Sinha","year":"2011","journal-title":"Dermatol Clin"},{"issue":"25","key":"10.1016\/j.autrev.2019.02.005_bb0105","doi-asserted-by":"crossref","first-page":"11935","DOI":"10.1073\/pnas.92.25.11935","article-title":"Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris","volume":"92","author":"Wucherpfennig","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.autrev.2019.02.005_bb0110","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4843","key":"10.1016\/j.autrev.2019.02.005_bb0115","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.2894075","article-title":"A newly characterized HLA DQ beta allele associated with pemphigus vulgaris","volume":"239","author":"Sinha","year":"1988","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1523-1747.ep12337585","article-title":"HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese","volume":"109","author":"Miyagawa","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0039.1994.tb02390.x","article-title":"HLA-DQA1, - DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method","volume":"44","author":"Niizeki","year":"1994","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2013.01.004","article-title":"Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.autrev.2008.07.021","article-title":"Pemphigus and infectious agents","volume":"8","author":"Sagi","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaut.2008.08.003","article-title":"Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity","volume":"31","author":"Culton","year":"2008","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0145","doi-asserted-by":"crossref","first-page":"A379","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2019.02.005_bb0150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.autrev.2016.07.005","article-title":"Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease","volume":"15","author":"Qian","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0155","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting Edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1399-0039.1997.tb02707.x","article-title":"An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations","volume":"49","author":"Moraes","year":"1997","journal-title":"Tissue Antigens"},{"issue":"25","key":"10.1016\/j.autrev.2019.02.005_bb0165","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.autrev.2019.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0175","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2019.02.005_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.autrev.2014.01.047","article-title":"Diagnosis and classification of autoimmune blistering diseases","volume":"13","author":"Baum","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2019.02.005_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2019.02.005_bb0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.survophthal.2015.12.007","article-title":"Update on ocular cicatricial pemphigoid and emerging treatments","volume":"61","author":"Queisi","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2017.02.019","article-title":"Spectrum of orocutaneous disease associations: Immune-mediated conditions","volume":"77","author":"Cizenski","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2011.05.017","article-title":"Autoimmune blistering diseases of the skin","volume":"11","author":"Sticherling","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0215","first-page":"191","article-title":"Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy","volume":"17","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0225","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","article-title":"Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.autrev.2019.02.005_bb0230","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.005_bb0235","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/jama.1991.03470110089038","article-title":"Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome","volume":"266","author":"Chan","year":"1991","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clindermatol.2011.03.007","article-title":"Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid)","volume":"30","author":"Chan","year":"2012","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00003226-199809000-00007","article-title":"The association between ocular cicatricial pemphigoid and rheumatoid arthritis","volume":"17","author":"Olsen","year":"1998","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clindermatol.2010.07.010","article-title":"Autoimmune blistering diseases in the elderly","volume":"29","author":"Parker","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.autrev.2019.02.005_bb0260","first-page":"244","article-title":"Patologia oral y maxilofacial contemporanea","author":"Sapp","year":"1998","journal-title":"Madrid: Harcourt Editores"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0265","first-page":"184","article-title":"Desquamative gingivitis as a manifestation of chronic mucocutaneous disease","volume":"9","author":"Gagari","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0270","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2016.10.028","article-title":"Periodontitis in oral pemphigus and pemphigoid: a systematic review of published studies","volume":"76","author":"Jascholt","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0275","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0280","first-page":"26","article-title":"Recurrent Aphthous Stomatitis: a Review","volume":"10","author":"Edgar","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0285","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2005.10.019","article-title":"The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus","volume":"54","author":"Uzun","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2334\/josnusd.49.89","article-title":"Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation","volume":"49","author":"Ismail","year":"2007","journal-title":"J Oral Sci"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0295","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/adj.12335","article-title":"Oral candidal carriage in asymptomatic patients","volume":"61","author":"Mun","year":"2016","journal-title":"Aust Dent J"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2019.02.005_bb0305","first-page":"E622","article-title":"Pemphigus vulgaris in oral cavity: clinical analysis of 71 cases","volume":"13","author":"Shamim","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.005_bb0310","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1468-3083.2011.04046.x","article-title":"The Tzanck smear: an auspicable return to the past","volume":"25","author":"Angelini","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"issue":"12","key":"10.1016\/j.autrev.2019.02.005_bb0320","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI10305","article-title":"Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions","volume":"106","author":"Nguyen","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2133.1999.02612.x","article-title":"Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions","volume":"140","author":"Scully","year":"1999","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cden.2004.08.002","article-title":"Pemphigus","volume":"49","author":"Ettlin","year":"2005","journal-title":"Dent Clin N Am"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0345","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.005_bb0350","article-title":"Anti-CD20 monoclonal antibody (rituximab) in the treatment of autoimmune diseases. Successful result in refractory Pemphigus vulgaris: report of a case","volume":"88","author":"Virgolini","year":"2003","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0355","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0190-9622(90)70004-2","article-title":"Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies","volume":"22","author":"Tan-Lim","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0365","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.1996.tb06349.x","article-title":"Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis","volume":"134","author":"Izaki","year":"1996","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.005_bb0370","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2230.2011.04081.x","article-title":"Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection","volume":"36","author":"Jing","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0375","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2340\/0001555575150152","article-title":"The steroid-sparing effect of long-term plasmapheresis in pemphigus","volume":"75","author":"Sondergaard","year":"1995","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0380","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0385","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/exd.12355","article-title":"Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins","volume":"23","author":"Langenhan","year":"2014","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0390","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.autrev.2014.12.002","article-title":"A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab","volume":"14","author":"Ahmed","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2019.02.005_bb0395","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"17","key":"10.1016\/j.autrev.2019.02.005_bb0400","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0405","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2133.2011.10585.x","article-title":"Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine\/mycophenolate mofetil: a pilot study of 23 patients","volume":"166","author":"Kasperkiewicz","year":"2012","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0410","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","article-title":"Treatment of severe pemphigus with protein a immunoadsorption, rituximab and intravenous immunoglobulins","volume":"158","author":"Shimanovich","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.005_bb0415","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13555-012-0017-3","article-title":"Rituximab in the treatment of pemphigus vulgaris","volume":"2","author":"Zakka","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0420","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.12073","article-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","volume":"38","author":"Sharma","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"175","key":"10.1016\/j.autrev.2019.02.005_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0430","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0378-6323.174379","article-title":"Clinical efficacy of rituximab in the treatment of pemphigus: a retrospective study","volume":"82","author":"Sharma","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0435","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2011.10663.x","article-title":"Low-dose rituximab is effective in pemphigus","volume":"166","author":"Horvath","year":"2012","journal-title":"Br J Dermatol"},{"issue":"10083","key":"10.1016\/j.autrev.2019.02.005_bb0440","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0445","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/jamadermatol.2015.59","article-title":"Persistence of autoreactive IgA-secreting B cells despite multiple immunosuppressive medications including rituximab","volume":"151","author":"He","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0450","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000070972","article-title":"Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A","volume":"109","author":"Gergely","year":"2003","journal-title":"Acta Haematol"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.005_bb0455","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/imj.12576","article-title":"Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy","volume":"44","author":"Hwang","year":"2014","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0460","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1172\/JCI46110","article-title":"CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients","volume":"121","author":"Savoldo","year":"2011","journal-title":"J Clin Invest"},{"issue":"6295","key":"10.1016\/j.autrev.2019.02.005_bb0465","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.autrev.2019.02.005_bb0470","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0475","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen- specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.autrev.2019.02.005_bb0480","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200565130-00003","article-title":"Autoimmune bullous diseases: ocular manifestations and management","volume":"65","author":"Laforest","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0485","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:INTE.0000031736.69290.18","article-title":"Severe conjunctival and eyelid involvement in pemphigus vulgaris","volume":"25","author":"Lifshitz","year":"2004","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0490","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2005.02.061","article-title":"Ocular pemphigus","volume":"53","author":"Daoud","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0495","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s003470050021","article-title":"Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications","volume":"97","author":"Messmer","year":"2000","journal-title":"Ophthalmologe"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.005_bb0500","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1346-8138.12447","article-title":"Ocular involvement in pemphigus vulgaris","volume":"41","author":"Akhyani","year":"2014","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ICL.0000000000000155","article-title":"Pemphigus: an ophthalmological review","volume":"42","author":"Chirinos-Saldana","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.005_bb0510","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000355374","article-title":"Pathological findings of pemphigus vulgaris showing giant cobblestone-like conjunctival papillae","volume":"4","author":"Namba","year":"2013","journal-title":"Case Rep Ophthalmol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0515","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/dth.12386","article-title":"Successful treatment with oral mizoribine in refractory ocular manifestation of mucosal pemphigus vulgaris: a unique response to different immunosuppressive drugs","volume":"29","author":"Oyama","year":"2016","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0520","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1590\/abd1806-4841.20142679","article-title":"Evaluation of cases of pemphigus vulgaris and pemphigus foliaceus from a reference service in Para state, Brazil","volume":"89","author":"Pires","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.005_bb0525","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0530","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ophtha.2009.09.006","article-title":"Paraneoplastic conjunctival cicatrization: two different pathogenic types","volume":"117","author":"Ahuero","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2019.02.005_bb0535","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2008.1306","article-title":"Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitis","volume":"2009","author":"Tam","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2019.02.005_bb0540","first-page":"1","article-title":"Incidence and clinical characteristics of ocular involvement in mucous membrane pemphigoid","author":"Hong","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0545","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcjo.2014.11.012","article-title":"Characteristics of patients with ocular cicatricial pemphigoid referred to major tertiary hospital","volume":"50","author":"Goldich","year":"2015","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0550","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtos.2013.02.003","article-title":"Current medical treatment of ocular mucous membrane pemphigoid","volume":"11","author":"Sobolewska","year":"2013","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.005_bb0555","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-9394(14)70495-7","article-title":"Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices","volume":"122","author":"Secchi","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.005_bb0560","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1902\/jop.2009.090244","article-title":"A comparison of the periodontal status in patients with mucous membrane pemphigoid: a 5-year follow-up","volume":"80","author":"Schellinck","year":"2009","journal-title":"J Periodontol"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0565","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.4317\/medoral.17809","article-title":"Clinical and histological features of gingival lesions: a 17-year retrospective analysis in a northern Italian population","volume":"17","author":"Carbone","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.autrev.2019.02.005_bb0570","doi-asserted-by":"crossref","first-page":"747506","DOI":"10.1155\/2014\/747506","article-title":"Conservative approach in patients with pemphigus gingival vulgaris: a pilot study of five cases","volume":"2014","author":"Gambino","year":"2014","journal-title":"Int J Dent"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.005_bb0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1601-5037.2011.00527.x","article-title":"Professional oral hygiene treatment and detailed oral hygiene instructions in patients affected by mucous membrane pemphigoid with specific gingival localization: a pilot study in 12 patients","volume":"10","author":"Arduino","year":"2012","journal-title":"Int J Dent Hyg"},{"key":"10.1016\/j.autrev.2019.02.005_bb0580","first-page":"57","article-title":"Dental care before cardiac valve surgery: is it important to prevent infective endocarditis?","volume":"12","author":"de Souza","year":"2016","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.005_bb0585","first-page":"271","article-title":"Gingival disorders of immune origin","volume":"7","author":"Castellano Suarez","year":"2002","journal-title":"Med Oral"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721930031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:15:58Z","timestamp":1761599758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721930031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S156899721930031X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.02.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}